Texas health care worker who treated Thomas Eric Duncan tests positive for Ebola


A health care worker who helped treat Thomas Eric Duncan earlier this week has preliminarily tested positive for the Ebola virus. If confirmatory tests administered by the Centers for Disease Control and Prevention also are positive, the new patient will be the first to contract Ebola on U.S. soil, The Associated Press reports.
"We knew a second case could be a reality, and we've been preparing for this possibility," Dr. David Lakey, commissioner of the Texas Department of State Health Services, said. "We are broadening our team in Dallas and working with extreme diligence to prevent further spread."
The new patient's name and the capacity in which he or she provided treatment to Duncan was not immediately identified. Officials told AP that the patient was placed in isolation on Friday night after reporting a low-grade fever and undergoing preliminary testing. Health officials are now identifying any individuals the new patient may have come in contact with after his or her symptoms began.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Thomas Eric Duncan died last week at Texas Health Presbyterian Hospital, in Dallas. He had left Liberia in mid-September and traveled to the United States to reunite with relatives, but he had been exposed to the Ebola virus while helping a pregnant neighbor in Liberia.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Sarah Eberspacher is an associate editor at TheWeek.com. She has previously worked as a sports reporter at The Livingston County Daily Press & Argus and The Arizona Republic. She graduated from Northwestern University's Medill School of Journalism.
-
Tuberculosis is seeing a resurgence, and it's only going to get worse
Under the radar The spread of the deadly infection is buoyed by global unrest
By Devika Rao, The Week US Published
-
Sudoku hard: April 03, 2025
The Week's daily hard sudoku puzzle
By The Week Staff Published
-
Codeword: April 3, 2025
The Week's daily codeword puzzle
By The Week Staff Published
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
By Peter Weber, The Week US Published
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
By Peter Weber, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published